Granuflo is a common drug used by dialysis centers across the country. Given to those who suffer from acute or chronic kidney failure, Granuflo is meant to facilitate dialysis, a process in which water and excess waste are removed from the blood. It is a dry-acid product and is manufactured by German healthcare company Fresenius.
Recently, Granuflo has received mass attention for being potentially dangerous, leading to an FDA recall of the drug initiated in March 2012. Since then, Fresenius-owned dialysis centers have been under investigation, and patients have initiated hundreds of lawsuits to recover damages.